Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
March 01, 2025 12:45 ET | Source: Celldex Therapeutics, Inc. - Greatly…
Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches
ZUG, Switzerland, Feb. 18, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a…
Publications from all previous Olympic Games in Italy digitised by the Olympic Studies Centre
06 February 2025 - To celebrate the one-year countdown to the Olympic Winter…
Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and…
Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and…
Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and…
Axtria Unveils New US and Global Incentive Compensation Benchmarking Studies: Insights That Drive Life Sciences Success
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and…